SymBio Pharmaceuticals Limited (TYO:4582)

Japan · Delayed Price · Currency is JPY

128.00

+7.00 (5.79%)

Mar 5, 2026, 3:30 PM JST

Revenue by Segment

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Research and Development, Manufacturing and Sales of Pharmaceuticals	1.31B	2.45B	5.59B	10.01B	8.26B
Research and Development, Manufacturing and Sales of Pharmaceuticals Growth	-46.67%	-56.13%	-44.15%	21.21%	176.42%
Total	1.31B	2.45B	5.59B	10.01B	8.26B
Total Growth	-46.67%	-56.13%	-44.15%	21.21%	176.42%

Revenue by Geography

Financials in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Japan	1.31B	2.45B	5.59B	10.01B	8.26B
Japan Growth	-46.67%	-56.13%	-44.15%	21.21%	176.42%
Total	1.31B	2.45B	5.59B	10.01B	8.26B
Total Growth	-46.67%	-56.13%	-44.15%	21.21%	176.42%

Source: S&P Global Market Intelligence.